Effects of 7-valent pneumococcal conjugate 1 vaccine on the severity of adult 2 bacteremic pneumococcal pneumonia

Vaccine

Volumn 32, Issue 31, 2014, Pages 3989-3994

  Cremers, Amelieke J H ^a   Meis, Jacques F ^a,b   Walraven, Grietje ^a   Jongh, Christa E van der Gaast de ^a   Ferwerda, Gerben ^a   Hermans, Peter W M ^a,c  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^c CRUCELL HOLLAND BV   (Netherlands)

Author keywords

Bacteremic pneumococcal pneumonia; Pneumococcal serotypes; Pneumococcal vaccination; Severity of disease

Indexed keywords

PNEUMOCOCCUS VACCINE; HEPTAVALENT PNEUMOCOCCAL CONJUGATE VACCINE; VACCINE;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; COMORBIDITY; DISEASE SEVERITY; DRUG EFFECT; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OBSERVATIONAL STUDY; PLEURA EFFUSION; PLEURA EMPYEMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEROTYPE; STREPTOCOCCUS PNEUMONIA; VACCINATION; CLASSIFICATION; LENGTH OF STAY; MIDDLE AGED; NETHERLANDS; PNEUMONIA, PNEUMOCOCCAL; SEROTYPING; SEVERITY OF ILLNESS INDEX; STREPTOCOCCUS PNEUMONIAE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; NETHERLANDS; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; SEROTYPING; SEVERITY OF ILLNESS INDEX; STREPTOCOCCUS PNEUMONIAE; VACCINES, CONJUGATE;

EID: 84901982172     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.04.089     Document Type: Article

References (22)

1. Said M.A., Johnson H.L., Nonyane B.A.S., Deloria-Knoll M., O'Brien K.L., et al. Estimating the burden of Pneumococcal Pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques. PLoS One 2013, 8:e60273.
2. Bordon J., Peyrani P., Brock G.N., Blasi F., Rello J., File T., et al. The presence of pneumococcal bacteremia does not influence clinical outcomes in patients with community-acquired pneumonia: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort study. Chest 2008, 133:618-624.
3. Butler J.C., Shapiro E.D., Carlone G.M. Pneumococcal vaccines: history, current status, and future directions. Am J Med 1999, 107:69S-76S.
4. Hicks L.A., Harrison L.H., Flannery B., Hadler J.L., Schaffner W., Craig A.S., et al. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis 2007, 196:1346-1354.
5. Weinberger D.M., Malley R., Lipsitch M. Serotype replacement in disease after pneumococcal vaccination. Lancet 2011, 378:1962-1973.
6. Miller E., Andrews N.J., Waight P.A., Slack M.P., George R.C. Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study. Lancet Infect Dis 2011, 11:760-768.
7. Elberse K.E., van der Heide H.G., Witteveen S., van de Pol I., Schot C.S., van der Ende A., et al. Changes in the composition of the pneumococcal population and in IPD incidence in The Netherlands after the implementation of the 7-valent pneumococcal conjugate vaccine. Vaccine 2012, 30:7644-7651.
8. Martens P., Worm S.W., Lundgren B., Konradsen H.B., Benfield T. Serotype-specific mortality from invasive Streptococcus pneumoniae disease revisited. BMC Infect Dis 2004, 4:21.
9. Alanee S.R., McGee L., Jackson D., Chiou C.C., Feldman C., Morris A.J., et al. Association of serotypes of Streptococcus pneumoniae with disease severity and outcome in adults: an international study. Clin Infect Dis 2007, 45:46-51. An official publication of the Infectious Diseases Society of America.
10. Harboe Z.B., Thomsen R.W., Riis A., Valentiner-Branth P., Christensen J.J., Lambertsen L., et al. Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study. PLoS Med 2009, 6:e1000081.
11. Weinberger D.M., Harboe Z.B., Sanders E.A., Ndiritu M., Klugman K.P., Ruckinger S., et al. Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis. Clin Infect Dis 2010, 51:692-699. An Official Publication of the Infectious Diseases Society of America.
12. Lujan M., Gallego M., Belmonte Y., Fontanals D., Valles J., Lisboa T., et al. Influence of pneumococcal serotype group on outcome in adults with bacteraemic pneumonia. Eur Respir J 2010, 36:1073-1079. Official Journal of the European Society for Clinical Respiratory Physiology.
13. Fine M.J., Auble T.E., Yealy D.M., Hanusa B.H., Weissfeld L.A., Singer D.E., et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997, 336:243-250.
14. Pai R., Gertz R.E., Beall B. Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates. J Clin Microbiol 2006, 44:124-131.
15. Benjamini Y.H.Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc, Ser B (Methodological) 1995, 57:289-300.
16. Bacterial meningitis in The Netherlands Annual Report 2010, Netherlands Reference Laboratory for Bacterial Meningitis (AMC/RIVM).
17. Rello J., Lujan M., Gallego M., Valles J., Belmonte Y., Fontanals D., et al. Why mortality is increased in health-care-associated pneumonia: lessons from pneumococcal bacteremic pneumonia. Chest 2010, 137:1138-1144.
18. Johnstone J., Eurich D.T., Majumdar S.R., Jin Y., Marrie T.J. Long-term morbidity and mortality after hospitalization with community-acquired pneumonia: a population-based cohort study. Medicine 2008, 87:329-334.
19. Burgos J., Lujan M., Falco V., Sanchez A., Puig M., Borrego A., et al. The spectrum of pneumococcal empyema in adults in the early 21st century. Clin Infect Dis 2011, 53:254-261. An Official Publication of the Infectious Diseases Society of America.
20. Grau I., Ardanuy C., Calatayud L., Rolo D., Domenech A., Linares J., et al. Invasive pneumococcal disease in healthy adults: increase of empyema associated with the clonal-type Sweden(1)-ST306. PLoS One 2012, 7:e42595.
21. van Deursen A.M.M., van Mens S.P., Sanders E.A.M., Vlaminckx B.J.M., de Melker H.E., Schouls L.M., et al. Invasive pneumococcal disease and 7-valent pneumococcal conjugate vaccine, The Netherlands. Emerg Infect Dis 2012, 18:1729-1737.
22. Bewick T., Sheppard C., Greenwood S., Slack M., Trotter C., George R., et al. Serotype prevalence in adults hospitalised with pneumococcal non-invasive community-acquired pneumonia. Thorax 2012, 67:540-545.